Both in Pharmaceuticals
PepGen vs Oramed Pharmaceuticals
Over the past year PEPG returned −49.2% and ORMP returned +76.3%; their daily moves had a correlation of 0.06.
PEPG −49.2% ORMP +76.3%Growth of $1, one year, split-adjusted
| Metric | PEPG | ORMP |
|---|---|---|
| Price | $2.53 | $4.16 |
| Market cap | $175.2M | $173.0M |
| Today | −2.69% | 0.00% |
| 1 month | +8.1% | −11.3% |
| 6 months | +63.2% | +8.3% |
| Year to date | −61.1% | +46.0% |
| 1 year | −53.4% | +75.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 1.0× |
| Price / sales | — | — |
| Net cash | $117.2M | $50.6M |
| Dividend yield | — | 6.01% |
| Volatility (60d) | 85.5% | 35.7% |
| Short % of float | 9.6% | 4.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).